(Q64122144)
Statements
A Phase 1, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adult Participants With Amyotrophic Lateral Sclerosis (English)
0 references
19 June 2019
0 references
31 December 2020
0 references
40
0 references
18 year
0 references